Targeted Cancer Therapies
Tumor Progression
Cancer
Cancer Survival Analysis
Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 16, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
M Walid Qoronfleh1,2,3, Nader Al-Dewik4,5,6
1Healthcare Research & Policy Division, Q3 Research Institute (QRI), Ypsilanti, MI 48917, USA.
This perspective highlights cancer biomarkers for early detection, personalized treatment, and innovation. Artificial intelligence (AI) is revolutionizing biomarker development by analyzing complex data for precision oncology.
Area of Science:
Background: